PT Kalbe Farma Tbk (PTKFY)
PT Kalbe Farma Tbk operates in the Drug Manufacturers - General industry of the Healthcare sector, headquartered in Jakarta, JK, ID. The stock last traded at $8.78, up 0.00% on the session, giving a market capitalisation of $9.9M. On trailing twelve-month figures it carries a trailing P/E of 10.05, a net margin of 9.6%. Its beta of 0.05 implies it has historically moved less than the broad market.
PT Kalbe Farma Tbk is engaged in the development, distribution, and trading of pharmaceutical products. It operates through the following divisions: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical division offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores. The Consumer Health division includes over-the-counter drugs, consumer products, food supplements, preventive products, energy drinks, and healthy ready-to-drink products. The Nutritionals division sells biscuits, cereals, and milk products for infants, toddlers, children, pre-teenagers, adults, expectant and lactating mothers, and elderly; as well as nutritional products for consumers with special medical needs. The Distribution and Logistic division maintains distribution of the company's and third party principal's products across Indonesia; and focuses on the trading of raw material, medical devices, and retail health service. The company founded by Boenyamin Setiawan on September 10, 1966 and is headquartered in Jakarta, Indonesia.
PT Kalbe Farma Tbk is most often compared with the following Healthcare names: